Evidence map›Paper›PMID 41975092›Full record

ArticleNature microbiology2026

Long-term HIV-1 remission achieved through allogeneic haematopoietic stem cell transplant from a CCR5Δ32/Δ32 sibling donor.

Anders Eivind Myhre, Malin Holm Meyer-Myklestad, Hanne Hestdal Gullaksen, Ole S Søgaard, Martin Tolstrup, Maria Salgado, Javier Martinez-Picado, Mona Holberg-Petersen, Anna Karina Juhl, Mariane H Schleimann and 14 more

Abstract readCase Reports
In one paragraph

Article in Nature microbiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

24 authors.

Anders Eivind Myhre *Department of Haematology, Oslo University Hospital, Oslo, Norway. andmyhr@ous-hf.no.ORCID http://orcid.org/0009-0005-8459-4209
Malin Holm Meyer-Myklestad *Department of Microbiology, Oslo University Hospital, Oslo, Norway.ORCID http://orcid.org/0000-0003-3162-5196
Hanne Hestdal GullaksenDepartment of Infectious Diseases, Oslo University Hospital, Oslo, Norway.ORCID http://orcid.org/0009-0007-1177-4262
Ole S SøgaardDepartment of Infectious Diseases, Aarhus University Hospital, Aarhus, Denmark.ORCID http://orcid.org/0000-0001-9107-2023
Martin TolstrupDepartment of Infectious Diseases, Aarhus University Hospital, Aarhus, Denmark.
Maria SalgadoIrsiCaixa, Barcelona, Spain.
Javier Martinez-PicadoIrsiCaixa, Barcelona, Spain.ORCID http://orcid.org/0000-0002-4916-2129
Mona Holberg-PetersenDepartment of Microbiology, Oslo University Hospital, Oslo, Norway.
Anna Karina JuhlDepartment of Infectious Diseases, Aarhus University Hospital, Aarhus, Denmark.
Mariane H SchleimannDepartment of Infectious Diseases, Aarhus University Hospital, Aarhus, Denmark.
Jesper D GunstDepartment of Infectious Diseases, Aarhus University Hospital, Aarhus, Denmark.ORCID http://orcid.org/0000-0002-3787-0259
Astrid ThomsenDepartment of Infectious Diseases, Aarhus University Hospital, Aarhus, Denmark.
Katie FisherDepartment of Infectious Diseases, Aarhus University Hospital, Aarhus, Denmark.ORCID http://orcid.org/0000-0002-8732-706X
Jagjit Singh BhamraDepartment of Immunology and Transfusion Medicine, Oslo University Hospital, Oslo, Norway.ORCID http://orcid.org/0000-0002-8423-8440
Anne-Marte Bakken KranDepartment of Microbiology, Oslo University Hospital, Oslo, Norway.
Bente HalvorsenInstitute of Clinical Medicine, University of Oslo, Oslo, Norway.
Anne Ma Dyrhol-RiiseDepartment of Infectious Diseases, Oslo University Hospital, Oslo, Norway.
Dag Henrik ReikvamDepartment of Infectious Diseases, Oslo University Hospital, Oslo, Norway.
Pål AukrustInstitute of Clinical Medicine, University of Oslo, Oslo, Norway.
Tobias Gedde-DahlDepartment of Haematology, Oslo University Hospital, Oslo, Norway.
Oslo HIV Cure Study Group
Tuva Børresdatter DahlResearch Institute of Internal Medicine, Oslo University Hospital, Oslo, Norway.ORCID http://orcid.org/0000-0001-7818-9411
Mari Kaarbø *Department of Microbiology, Oslo University Hospital, Oslo, Norway.
Marius Trøseid *Institute of Clinical Medicine, University of Oslo, Oslo, Norway. marius.troseid@medisin.uio.no.ORCID http://orcid.org/0000-0001-7775-3404

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Only few cases of human immunodeficiency virus (HIV) remission have been reported after allogeneic haematopoietic stem cell transplantation (HSCT), mostly involving stem cell donors with the homozygous CCR5Δ32 (CCR5Δ32/Δ32) mutation, which confers resistance to CCR5-tropic HIV-1. Here we report the case of a 63-year-old man in off-treatment HIV remission, 5 years after HSCT with a CCR5Δ32/Δ32 sibling donor for myelodysplastic syndrome. In-depth clinical characterization including virological and immunological analyses of peripheral blood, gut and bone marrow samples revealed that full donor chimerism was achieved. Antiretroviral therapy was discontinued after 24 months, and 48 months after HSCT, no intact HIV DNA was detected in blood or gut biopsies. Replication-competent virus and HIV-specific T cell responses were absent, and HIV antibody responses showed a gradual decline. Full donor chimerism in the gut, which is the primary viral reservoir, underscores the likelihood of a cure.

Indexed as

Hematopoietic Stem Cell TransplantationHIV-1HIV InfectionsReceptors, CCR5HumansMaleMiddle AgedMyelodysplastic SyndromesRemission InductionSiblingsTissue DonorsTransplantation, HomologousCCR5 protein, humanReceptors, CCR5

Identifiers

PMID41975092
PMCPMC13171445

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.